Search for: "PFIZER"
Results 1301 - 1320
of 4,626
Sort by Relevance
|
Sort by Date
25 May 2017, 5:00 am
Ed. [read post]
22 May 2017, 3:01 am
Registration closes on 25 May 2017and can be done here.London calling: On the other side of the Channel, the Competition Law Association (CLA) will host the lunchtime event Flynn Pharma and Pfizer: the IP and competition aspects of Phenytoin Sodium Flynn on 7 July 2017 at the Arnold & Porter Kaye Scholer LLP offices in London. [read post]
12 May 2017, 10:41 am
And the investigation of Baxter International, Pfizer and ICU Medical over their medical pricing and dealings with competitors. [read post]
5 May 2017, 11:24 am
The CAFC decision related to cases merged from different patent challenges at the PTAB level:This appeal arises from two inter partes reexaminationsand an ex parte reexamination of U.S. [read post]
30 Apr 2017, 4:30 am
Regulatory approval, trade secrets and the transatlantic biosimilars patent wars | Biosimilars and generics as "rip-offs": when the facts may not matter | UK's IP Enforcement Framework - IPO Research Bid Opportunity | Curtain - Merpel's final EPO post | Amgen, Pfizer, Alphabet and Uber face up to trade secrets in biosimilars, self driving cars and product launch plans | BREAKING: Politico publishes (part of) draft copyright report by MEP Comodini Cachia | Parallel… [read post]
27 Apr 2017, 6:49 am
Pfizer, which repatriated the most money under the 2004 holiday laid off 3,500 employees just after the holiday and closed factories. [read post]
15 Apr 2017, 4:17 am
|Never Too Late 140 [week ending on Sunday 19 March] | Friday Fantasies | Kat konfusion regarding passing off: likelihood of confusion and the Starbucks (HK) case | Thursday Thingies | Wednesday Whimsies | First live blocking order granted in the UK |The scope of a well-known mark: not always as broad as some might wish | Monday miscellany | Around the IP Blogs | UK's IP Enforcement Framework-IPO Research Bid Opportunity (Update) Never Too Late 139 [week ending on Sunday 12… [read post]
12 Apr 2017, 2:22 pm
An Observational Study Compared Myocardial Infarction / Heart Attack Risks As Between The Use Of Newer Blood Thinners And The Use Of Warfarin (Posted by Tom Lamb at DrugInjuryWatch.com) In the US, there are currently four direct-acting oral anticoagulants (DOACs), a relatively new class of blood thinners, approved for the prevention of stroke in patients with atrial fibrillation (AF): Pradaxa (dabigatran) -- approved by FDA in 2010 -- Boehringer Ingelheim Pharmaceuticals Xarelto… [read post]
12 Apr 2017, 10:15 am
(NYSE:BMY) and Pfizer, Inc. [read post]
12 Apr 2017, 1:16 am
|Never Too Late 140 [week ending on Sunday 19 March] | Friday Fantasies | Kat konfusion regarding passing off: likelihood of confusion and the Starbucks (HK) case | Thursday Thingies | Wednesday Whimsies | First live blocking order granted in the UK |The scope of a well-known mark: not always as broad as some might wish | Monday miscellany | Around the IP Blogs | UK's IP Enforcement Framework-IPO Research Bid Opportunity (Update) Never Too Late 139 [week ending on Sunday 12 March] | Friday… [read post]
10 Apr 2017, 10:15 am
Ironically, after the homes in the Fort Trumbull neighborhood were razed for the project, Pfizer never developed the property and it remains vacate today. [read post]
4 Apr 2017, 1:55 am
Eleonora Rosati calls for readers’ attention on the new event organised by TIPLO (The Intellectual Property Lawyers Organisation) in London on March 28, 2017.Last but not least, the weekly routines that bring round-ups for the latest IP happenings including events, book release and highlighted blog posts: Never too Late (here ,here and here), Friday Fantasies and Around the IP Blogs (and here) by InternKats Verónica Rodríguez Arguijo, Hayleigh Bosher and Tian… [read post]
26 Mar 2017, 1:49 am
Unfortunately for Pfizer, Justice Stephen Burley has denied its application for discovery, ruling its evidence insufficient to establish a ‘reasonable belief’, as opposed to a ‘mere suspicion’, that SBA is infringing its patents relating to a process for producing etanercept: Pfizer Ireland Pharmaceuticals v Samsung Bioepis AU Pty Ltd [2017] FCA 285. [read post]
24 Mar 2017, 9:00 am
Pfizer/Herb-agra case.Would this rule increase uncertainty for brand owners? [read post]
21 Mar 2017, 11:45 pm
Regulatory approval, trade secrets and the transatlantic biosimilars patent wars | Biosimilars and generics as "rip-offs": when the facts may not matter | UK's IP Enforcement Framework - IPO Research Bid Opportunity | Curtain - Merpel's final EPO post | Amgen, Pfizer, Alphabet and Uber face up to trade secrets in biosimilars, self driving cars and product launch plans | BREAKING: Politico publishes (part of) draft copyright report by MEP Comodini Cachia | Parallel… [read post]
17 Mar 2017, 1:59 pm
Hobson, a former Oppenheimer & Co. investment adviser in Providence, R.I. was sentenced to six months’ imprisonment Wednesday after he pleaded guilty to insider trading based on information from a childhood friend working at Pfizer Inc. [read post]
10 Mar 2017, 8:37 am
Pfizer has marketed Viagra to younger men. [read post]
10 Mar 2017, 4:37 am
— via Outten & Golden Employment Law Blog If workplaces want to cut back on burnout, vacation email bans may be a good start — via ABA Journal Daily News Phishing Scams Targeting HR and Payroll Are on the Rise this Tax Season — via California Employment Law Misuse of Former Employee’s Login Credentials Leads to $5.5 Million HIPAA Settlement — via HR Daily Advisor Crushin’ it: being cybersecure in 2017 —… [read post]
9 Mar 2017, 10:54 am
Senior marketing departure stokes suspicion, and then action, at Pfizer: Last week, a Pennsylvania federal judge ordered an ex parte temporary restraining order ("TRO") against Aimee de Blasis Amann, a former global marketing director for Pfizer who had been at Pfizer since May 2006. [read post]
1 Mar 2017, 3:08 pm
Pfizer also argued McKesson was fraudulently joined and it should not be considered when applying the forum defendant rule. [read post]
